Login to Your Account



In The Clinic NEWS
CHICAGO – Vowing to make precision medicine more than a hackneyed phrase, researchers at the ASCO annual meeting disclosed the launch of three separate but complementary efforts in what amounts to the "expansion of an ongoing dream," said past ASCO president Clifford Hudis.
CHICAGO – Merck & Co. Inc. and Dynavax Technologies Corp. have agreed to pursue dual trials investigating the potential for combining immunotherapies from both companies' pipelines to help patients with multiple cancers
Neurovive Pharmaceutical AB was dangling from the high wire after reporting a top-line analysis of the phase III CIRCUS study of Ciclomulsion, which indicated the study missed the primary clinical endpoint in patients with ST-segment elevation acute myocardial infarction.
More In The Clinic Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: